Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Screening Magnetic Resonance Imaging of the Brain in Patients With Metastatic Breast Cancer Managed With First/Second Line Chemotherapy or Inflammatory Breast Cancer Managed With Definitive Intent: A Prospective Study
Sponsor: Conquer Cancer Foundation
A NA clinical study on Breast Cancer and HER2-positive Breast Cancer, this trial is actively recruiting participants. The trial is conducted by Conquer Cancer Foundation and has accumulated 11 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Nov 2024 — Present [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2023 — Oct 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2022 — Jan 2023 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Dec 2019 — Feb 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Conquer Cancer Foundation
- Dana-Farber Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .